CERTOLIZUMAB PEGOL

CERTOLIZUMAB PEGOL was reported 0 times

CERTOLIZUMAB PEGOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BASFI SCORE INCREASED 34 0.8293
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5659 0.7890
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 496 0.7425
3 PEMPHIGUS 8861 0.7080
4 SWOLLEN JOINT COUNT INCREASED 2257 0.7071
5 RHEUMATIC FEVER 3066 0.6871
6 HEPATIC ENZYME 99 0.6644
7 RHEUMATOID FACTOR POSITIVE 3769 0.6519
8 DEEP VEIN THROMBOSIS POSTOPERATIVE 1290 0.6440
9 DUODENAL ULCER PERFORATION 4778 0.6419
10 LUPUS VULGARIS 796 0.6317
11 C-REACTIVE PROTEIN 584 0.6300
12 BASDAI SCORE INCREASED 42 0.6269
13 GRIP STRENGTH 139 0.6070
14 RED BLOOD CELL SEDIMENTATION RATE 161 0.5771
15 HAND DEFORMITY 7373 0.5616
16 FACET JOINT SYNDROME 1791 0.5496
17 COVID-19 IMMUNISATION 449 0.5377
18 SWOLLEN JOINT COUNT 128 0.5120
19 AXIAL SPONDYLOARTHRITIS 449 0.5108
20 MUSCLE INJURY 4016 0.4842
21 HELICOBACTER INFECTION 4860 0.4724
22 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 976 0.4706
23 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2956 0.4547
24 HEALTH ASSESSMENT QUESTIONNAIRE SCORE INCREASED 47 0.4519
25 SYNOVIAL FLUID ANALYSIS 39 0.4483
26 FOLLICULITIS 4551 0.4336
27 X-RAY ABNORMAL 764 0.4268
28 SYNOVITIS 7501 0.4156
29 RHEUMATOID FACTOR NEGATIVE 72 0.4114
30 DISLOCATION OF VERTEBRA 925 0.4052
31 INFLUENZA IMMUNISATION 34 0.3820
32 C-REACTIVE PROTEIN ABNORMAL 2397 0.3733
33 RETINITIS 641 0.3707
34 GLOSSODYNIA 8244 0.3679
35 BLOOD IRON ABNORMAL 344 0.3521
36 PERICARDITIS 5884 0.3499
37 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 188 0.3351
38 SERONEGATIVE ARTHRITIS 381 0.3325
39 PERIPHERAL VENOUS DISEASE 1302 0.3185
40 GRANULOMA SKIN 252 0.3069
41 BONE EROSION 1065 0.3008
42 CYTOLOGY ABNORMAL 44 0.2933
43 ANKLE ARTHROPLASTY 105 0.2893
44 CONTRAINDICATED PRODUCT ADMINISTERED 8354 0.2756
45 SYSTEMIC LUPUS ERYTHEMATOSUS 9289 0.2614
46 SARS-COV-2 TEST NEGATIVE 176 0.2607
47 MATERNAL EXPOSURE BEFORE PREGNANCY 1738 0.2542
48 WOUND 6846 0.2447
49 DRUG TOLERANCE DECREASED 671 0.2387
50 ANKYLOSING SPONDYLITIS 3041 0.2305
51 HYPOCHOLESTEROLAEMIA 81 0.2295
52 BREAST CANCER STAGE III 1409 0.2173
53 IRRITABLE BOWEL SYNDROME 4555 0.2122
54 ENTHESOPATHY 316 0.2019
55 MATERNAL EXPOSURE DURING BREAST FEEDING 814 0.2004
56 ONYCHOMADESIS 824 0.1961
57 GRIP STRENGTH DECREASED 1714 0.1946
58 LIP DRY 1739 0.1913
59 BLOOD PARATHYROID HORMONE DECREASED 280 0.1888
60 NAIL OPERATION 78 0.1884
61 RETINAL DEPOSITS 38 0.1872
62 INJECTION SITE PALLOR 58 0.1835
63 HYPERCHOLESTEROLAEMIA 1765 0.1826
64 ONYCHOMYCOSIS 795 0.1810
65 RHEUMATOID ARTHRITIS 20222 0.1779
66 PSORIATIC ARTHROPATHY 7115 0.1751
67 PORPHYRIA ACUTE 251 0.1749
68 RHEUMATOID NODULE 467 0.1694
69 OVERLAP SYNDROME 116 0.1657
70 JOINT RANGE OF MOTION DECREASED 2193 0.1634
71 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 364 0.1578
72 BURSITIS 1913 0.1575
73 WOUND INFECTION 1670 0.1523
74 LIVE BIRTH 1258 0.1502
75 ARTHROPATHY 8222 0.1478
76 JOINT DESTRUCTION 225 0.1446
77 IMPAIRED HEALING 4679 0.1424
78 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 113 0.1416
79 BLEPHAROSPASM 887 0.1407
80 AUTOIMMUNE DISORDER 1361 0.1395
81 FIBROMYALGIA 3319 0.1364
82 THERAPEUTIC PRODUCT EFFECT DECREASED 6093 0.1359
83 HYPERMOBILITY SYNDROME 66 0.1325
84 TENOSYNOVITIS 365 0.1322
85 LOWER RESPIRATORY TRACT INFECTION 5754 0.1264
86 LIVER INJURY 3013 0.1226
87 PANNICULITIS 294 0.1214
88 NAIL DISORDER 1050 0.1199
89 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1321 0.1193
90 ARTHRODESIS 119 0.1169
91 BREAST FEEDING 91 0.1165
92 DEATH NEONATAL 157 0.1128
93 HIP ARTHROPLASTY 1726 0.1126
94 MATERNAL EXPOSURE DURING PREGNANCY 9987 0.1119
95 FINGER DEFORMITY 541 0.1116
96 SPONDYLOARTHROPATHY 66 0.1100
97 TENOSYNOVITIS STENOSANS 61 0.1095
98 BUNION OPERATION 59 0.1052
99 PUSTULAR PSORIASIS 361 0.1050
100 TYPE 2 DIABETES MELLITUS 3508 0.1041
101 FOOT DEFORMITY 1136 0.1024
102 MATERNAL EXPOSURE TIMING UNSPECIFIED 377 0.1003
103 SCIATICA 1599 0.1002
104 EXOSTOSIS 904 0.0989
105 CROHN'S DISEASE 675 0.0984
106 INFUSION RELATED REACTION 6369 0.0960
107 DISCOMFORT 5802 0.0950
108 SWELLING 8877 0.0948
109 OBESITY 1500 0.0941
110 HEPATIC ENZYME INCREASED 6309 0.0925
111 INSURANCE ISSUE 1408 0.0920
112 DRUG INTOLERANCE 8813 0.0911
113 BLISTER 4958 0.0882
114 LUPUS-LIKE SYNDROME 799 0.0880
115 KNEE ARTHROPLASTY 1851 0.0878
116 ALANINE AMINOTRANSFERASE ABNORMAL 185 0.0876
117 INFUSION SITE REACTION 261 0.0873
118 PULMONARY FIBROSIS 1671 0.0870
119 RHEUMATOID LUNG 83 0.0869
120 WALKING AID USER 562 0.0852
121 TWIN PREGNANCY 70 0.0832
122 JOINT SWELLING 9984 0.0826
123 TRANSAMINASES ABNORMAL 47 0.0808
124 SKIN NEOPLASM EXCISION 63 0.0805
125 SYNOVIAL DISORDER 36 0.0791
126 PRODUCT LABEL CONFUSION 461 0.0790
127 COELIAC DISEASE 757 0.0771
128 LOWER LIMB FRACTURE 1475 0.0767
129 JOINT ANKYLOSIS 43 0.0757
130 TREATMENT FAILURE 6258 0.0755
131 JOINT DISLOCATION 795 0.0751
132 STOMATITIS 4529 0.0746
133 VACCINATION COMPLICATION 61 0.0745
134 DRUG TOLERANCE 375 0.0741
135 EXTREMITY CONTRACTURE 47 0.0734
136 BLOOD CHOLESTEROL INCREASED 3390 0.0726
137 PALMOPLANTAR PUSTULOSIS 37 0.0699
138 NIGHT SWEATS 2237 0.0694
139 SPONDYLITIS 251 0.0690
140 BACK INJURY 748 0.0687
141 PRESCRIBED OVERDOSE 1312 0.0677
142 C-REACTIVE PROTEIN INCREASED 2442 0.0670
143 GAIT INABILITY 2226 0.0665
144 PRODUCT AVAILABILITY ISSUE 1471 0.0645
145 POLYARTHRITIS 336 0.0637
146 ILL-DEFINED DISORDER 3826 0.0629
147 BLOOD FOLATE DECREASED 45 0.0619
148 EXPOSURE VIA BREAST MILK 242 0.0607
149 CONGENITAL ANOMALY 466 0.0601
150 OSTEOARTHRITIS 2502 0.0590
151 MUSCULOSKELETAL STIFFNESS 5124 0.0584
152 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2798 0.0582
153 ABDOMINAL DISCOMFORT 9709 0.0578
154 EYE INJURY 172 0.0566
155 ULCER HAEMORRHAGE 382 0.0564
156 MOBILITY DECREASED 4009 0.0557
157 INFLAMMATION 2877 0.0557
158 SINUSITIS 5710 0.0557
159 PRESCRIBED UNDERDOSE 1100 0.0551
160 LIVER FUNCTION TEST INCREASED 1174 0.0546
161 EAR PAIN 1056 0.0543
162 INJECTION SITE DISCOLOURATION 677 0.0541
163 BREAST CANCER STAGE II 450 0.0540
164 SKIN NECROSIS 278 0.0535
165 MUSCLE SPASTICITY 655 0.0533
166 FOOT OPERATION 263 0.0531
167 DACTYLITIS 52 0.0530
168 PREGNANCY 1059 0.0528
169 COLITIS MICROSCOPIC 250 0.0527
170 ALOPECIA 10275 0.0523
171 EXPOSURE TO SARS-COV-2 88 0.0517
172 LARYNGEAL DISORDER 37 0.0512
173 JUVENILE IDIOPATHIC ARTHRITIS 125 0.0511
174 THERAPY INTERRUPTED 3651 0.0510
175 PRODUCT DISTRIBUTION ISSUE 471 0.0507
176 JOINT STIFFNESS 1308 0.0498
177 ABSCESS DRAINAGE 42 0.0484
178 SPINAL FUSION SURGERY 196 0.0483
179 PRERENAL FAILURE 68 0.0482
180 RHEUMATIC DISORDER 93 0.0481
181 BONE CYST 45 0.0480
182 GASTROINTESTINAL DISORDER 4289 0.0478
183 INTENTIONAL DOSE OMISSION 1350 0.0473
184 INFECTION 6831 0.0471
185 FINE MOTOR SKILL DYSFUNCTION 135 0.0466
186 HEPATIC CIRRHOSIS 871 0.0463
187 HYPERSENSITIVITY 8453 0.0455
188 SACROILIITIS 85 0.0450
189 ADVERSE REACTION 575 0.0433
190 LATENT TUBERCULOSIS 90 0.0429
191 INJURY 3014 0.0428
192 RASH VESICULAR 206 0.0426
193 WHEEZING 2525 0.0425
194 CAESAREAN SECTION 494 0.0424
195 TUBERCULIN TEST POSITIVE 107 0.0422
196 RECTAL ABSCESS 70 0.0417
197 MUSCULOSKELETAL PAIN 2184 0.0416
198 PERIPHERAL SWELLING 6289 0.0408
199 GENERAL PHYSICAL HEALTH DETERIORATION 4669 0.0403
200 ALLERGY TO CHEMICALS 50 0.0401
201 SCLERITIS 64 0.0399
202 NEOPLASM SKIN 62 0.0399
203 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2807 0.0394
204 DERMATITIS PSORIASIFORM 80 0.0391
205 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 92 0.0387
206 SLEEP DISORDER 2705 0.0383
207 ROAD TRAFFIC ACCIDENT 1602 0.0383
208 BODY TEMPERATURE INCREASED 780 0.0382
209 LUNG DISORDER 1845 0.0376
210 CANCER SURGERY 36 0.0376
211 CONTUSION 3607 0.0374
212 NORMAL NEWBORN 203 0.0373
213 EAR INFECTION 986 0.0370
214 EXPOSURE DURING PREGNANCY 2262 0.0364
215 JOINT ARTHROPLASTY 65 0.0363
216 OEDEMA 1953 0.0360
217 LIP ULCERATION 42 0.0359
218 EPICONDYLITIS 54 0.0358
219 TASTE DISORDER 720 0.0355
220 RESPIRATORY DISORDER 1049 0.0350
221 CONTRAINDICATION TO MEDICAL TREATMENT 53 0.0347
222 TONGUE DISORDER 250 0.0345
223 INTENTIONAL PRODUCT USE ISSUE 3014 0.0344
224 DRUG-INDUCED LIVER INJURY 1079 0.0344
225 NASOPHARYNGITIS 6337 0.0343
226 LIMB OPERATION 163 0.0339
227 PERIRECTAL ABSCESS 37 0.0334
228 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 570 0.0332
229 THERAPY NON-RESPONDER 1475 0.0328
230 SHOULDER ARTHROPLASTY 88 0.0326
231 LIVER DISORDER 1431 0.0322
232 LOW BIRTH WEIGHT BABY 251 0.0316
233 EPILEPSY 962 0.0314
234 NECK MASS 89 0.0314
235 FEAR OF INJECTION 224 0.0314
236 RUBBER SENSITIVITY 48 0.0313
237 PSORIASIS 4089 0.0313
238 GESTATIONAL DIABETES 149 0.0312
239 PULMONARY SARCOIDOSIS 35 0.0312
240 PRODUCT DISPENSING ISSUE 132 0.0308
241 PRODUCT USE ISSUE 5731 0.0305
242 NODULE 396 0.0303
243 ANKLE OPERATION 44 0.0298
244 ENCEPHALITIS VIRAL 36 0.0296
245 JOINT EFFUSION 202 0.0293
246 BLOOD IMMUNOGLOBULIN G INCREASED 35 0.0288
247 DELIRIUM 989 0.0285
248 HEPATITIS 728 0.0284
249 TONSILLITIS 148 0.0283
250 LIMB DEFORMITY 45 0.0283
251 ENTERITIS INFECTIOUS 47 0.0276
252 JOINT LOCK 78 0.0274
253 BASAL CELL CARCINOMA 427 0.0273
254 DISABILITY 540 0.0273
255 CONFUSIONAL STATE 4388 0.0271
256 SARS-COV-2 TEST POSITIVE 358 0.0271
257 ARTHRALGIA 11196 0.0269
258 INABILITY TO AFFORD MEDICATION 266 0.0268
259 ARTHRITIS BACTERIAL 109 0.0265
260 PAIN 16271 0.0265
261 URTICARIA 4428 0.0264
262 UVEITIS 354 0.0261
263 ULCER 415 0.0261
264 ANAL ABSCESS 140 0.0259
265 DRY MOUTH 2104 0.0259
266 ARTHRITIS 2038 0.0259
267 FREQUENT BOWEL MOVEMENTS 698 0.0258
268 RASH 11259 0.0258
269 WHEELCHAIR USER 113 0.0254
270 OSTEOPOROSIS 1044 0.0254
271 SURGERY 1473 0.0251
272 HERNIA REPAIR 65 0.0250
273 THERAPEUTIC RESPONSE SHORTENED 826 0.0249
274 UPPER RESPIRATORY TRACT INFECTION 1150 0.0249
275 HYPOAESTHESIA 3719 0.0248
276 SYNOVIAL CYST 113 0.0244
277 INJECTION SITE REACTION 1679 0.0244
278 GRANULOMA 84 0.0242
279 MYOSITIS 217 0.0242
280 DISSEMINATED TUBERCULOSIS 61 0.0238
281 CATARACT OPERATION 141 0.0237
282 ABSCESS INTESTINAL 51 0.0237
283 DEFORMITY 219 0.0234
284 GENERAL SYMPTOM 174 0.0232
285 HYPERCALCAEMIA 286 0.0231
286 ADVERSE DRUG REACTION 2075 0.0231
287 CONDITION AGGRAVATED 6950 0.0228
288 ABDOMINAL ABSCESS 101 0.0228
289 HIP SURGERY 123 0.0227
290 NECK PAIN 1262 0.0226
291 WEIGHT INCREASED 5016 0.0224
292 TOOTH INFECTION 294 0.0223
293 ADVERSE EVENT 2053 0.0223
294 GASTROINTESTINAL TOXICITY 107 0.0222
295 TENDONITIS 344 0.0222
296 PREMATURE DELIVERY 353 0.0221
297 IMMUNODEFICIENCY 329 0.0220
298 MEAN CELL VOLUME DECREASED 34 0.0220
299 MIGRAINE 2082 0.0218
300 PHARYNGITIS STREPTOCOCCAL 236 0.0218
301 SPINAL STENOSIS 90 0.0218
302 PULMONARY TOXICITY 154 0.0218
303 IMMOBILE 95 0.0217
304 IRITIS 66 0.0217
305 INFLAMMATORY MARKER INCREASED 107 0.0216
306 NERVE INJURY 239 0.0215
307 KNEE OPERATION 211 0.0214
308 DYSPEPSIA 2104 0.0214
309 COLOSTOMY 42 0.0214
310 STREPTOCOCCAL INFECTION 118 0.0212
311 ANAL FISTULA 112 0.0210
312 HYPERTENSION 4433 0.0209
313 DENGUE FEVER 48 0.0209
314 ARTHRITIS INFECTIVE 97 0.0209
315 DRUG INEFFECTIVE 27487 0.0208
316 PULMONARY TUBERCULOSIS 89 0.0208
317 KIDNEY INFECTION 406 0.0207
318 ABSCESS 327 0.0205
319 LYME DISEASE 68 0.0204
320 NEUROGENIC BLADDER 43 0.0204
321 BRONCHITIS 1501 0.0203
322 SKIN REACTION 285 0.0202
323 SARCOIDOSIS 95 0.0200
324 ANTINUCLEAR ANTIBODY POSITIVE 64 0.0197
325 PREMATURE RUPTURE OF MEMBRANES 47 0.0195
326 INTESTINAL STENOSIS 81 0.0192
327 SKIN ULCER 495 0.0191
328 FUNGAL SKIN INFECTION 77 0.0191
329 FISTULA 214 0.0190
330 GLAUCOMA 365 0.0189
331 ABORTION 55 0.0188
332 HERPES ZOSTER 1077 0.0187
333 PRE-ECLAMPSIA 89 0.0187
334 OSTEOLYSIS 38 0.0186
335 SPINAL OPERATION 229 0.0186
336 MEAN CELL HAEMOGLOBIN DECREASED 34 0.0186
337 ILEOSTOMY 47 0.0184
338 DIVERTICULITIS 509 0.0183
339 PULMONARY MASS 273 0.0183
340 NEPHROLITHIASIS 839 0.0183
341 INFECTIOUS MONONUCLEOSIS 41 0.0183
342 INJECTION SITE VESICLES 110 0.0182
343 CREPITATIONS 54 0.0181
344 SHOULDER OPERATION 77 0.0180
345 ERYTHEMA NODOSUM 63 0.0179
346 DRUG ERUPTION 317 0.0179
347 PHYSICAL DISABILITY 79 0.0179
348 FATIGUE 13878 0.0178
349 GASTROENTERITIS VIRAL 319 0.0177
350 ABDOMINAL PAIN UPPER 3626 0.0176
351 VULVOVAGINAL MYCOTIC INFECTION 69 0.0175
352 SKIN INJURY 58 0.0175
353 SKIN PAPILLOMA 70 0.0174
354 BEDRIDDEN 229 0.0174
355 PLEURITIC PAIN 48 0.0174
356 ADRENAL INSUFFICIENCY 211 0.0174
357 POST PROCEDURAL INFECTION 141 0.0173
358 SUBCUTANEOUS ABSCESS 83 0.0173
359 COLONOSCOPY 38 0.0172
360 THERAPEUTIC RESPONSE DECREASED 1035 0.0171
361 SUSPECTED COVID-19 56 0.0170
362 ABORTION SPONTANEOUS 680 0.0170
363 PHARYNGITIS 210 0.0169
364 ORAL INFECTION 66 0.0169
365 PRODUCT PRESCRIBING ISSUE 366 0.0168
366 HEPATIC FIBROSIS 57 0.0166
367 BACK DISORDER 270 0.0166
368 JOINT INJURY 354 0.0166
369 PRURITUS 6366 0.0165
370 RASH PRURITIC 895 0.0165
371 MUSCULOSKELETAL DISORDER 312 0.0164
372 CUSHINGOID 52 0.0162
373 FOETAL DISTRESS SYNDROME 34 0.0160
374 FURUNCLE 127 0.0160
375 SYRINGE ISSUE 279 0.0159
376 PYREXIA 5511 0.0159
377 HIDRADENITIS 145 0.0159
378 AMNESIA 1030 0.0158
379 BREATH SOUNDS ABNORMAL 78 0.0158
380 INTESTINAL RESECTION 85 0.0158
381 ENDODONTIC PROCEDURE 40 0.0158
382 PRODUCT DOSE OMISSION 1017 0.0156
383 SMALL FOR DATES BABY 77 0.0155
384 SKIN INFECTION 174 0.0155
385 GALLBLADDER OPERATION 62 0.0153
386 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 259 0.0152
387 ASTHMA 1720 0.0152
388 FOOT FRACTURE 288 0.0152
389 CHONDROPATHY 41 0.0151
390 CLOSTRIDIAL INFECTION 51 0.0151
391 PNEUMONIA 4880 0.0151
392 RESPIRATORY TRACT CONGESTION 239 0.0150
393 NEEDLE ISSUE 437 0.0150
394 ERYSIPELAS 75 0.0149
395 PULMONARY CONGESTION 194 0.0147
396 ORAL DISCOMFORT 204 0.0147
397 PAIN IN EXTREMITY 4302 0.0146
398 GASTROINTESTINAL INFECTION 130 0.0145
399 INFREQUENT BOWEL MOVEMENTS 36 0.0144
400 PRODUCT DOSE OMISSION ISSUE 4250 0.0144
401 MUSCULAR WEAKNESS 1638 0.0144
402 RESPIRATORY TRACT INFECTION 375 0.0144
403 BRONCHIECTASIS 97 0.0144
404 APPENDICECTOMY 51 0.0143
405 POSTOPERATIVE WOUND INFECTION 96 0.0142
406 SUSPECTED OFF LABEL USE 64 0.0142
407 WEIGHT FLUCTUATION 148 0.0141
408 PLANTAR FASCIITIS 47 0.0140
409 INJECTION SITE RASH 429 0.0140
410 ORAL FUNGAL INFECTION 38 0.0139
411 LOCALISED INFECTION 335 0.0138
412 ENDOMETRIOSIS 66 0.0138
413 FOETAL GROWTH RESTRICTION 84 0.0138
414 ILLNESS 1418 0.0138
415 OFF LABEL USE 11976 0.0137
416 PARAESTHESIA 2151 0.0137
417 SERUM SICKNESS 38 0.0136
418 GASTROOESOPHAGEAL REFLUX DISEASE 1096 0.0136
419 MENOPAUSE 35 0.0136
420 INSOMNIA 3598 0.0135
421 SENSITIVITY TO WEATHER CHANGE 71 0.0135
422 PREMATURE BABY 404 0.0134
423 INFLAMMATORY BOWEL DISEASE 131 0.0134
424 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2406 0.0133
425 MEMORY IMPAIRMENT 1823 0.0133
426 DRUG SPECIFIC ANTIBODY PRESENT 86 0.0132
427 TOOTH ABSCESS 134 0.0131
428 LIMB DISCOMFORT 406 0.0131
429 GASTRIC DISORDER 450 0.0131
430 ROSACEA 61 0.0131
431 PYELONEPHRITIS 113 0.0130
432 HERPES VIRUS INFECTION 75 0.0130
433 MEDICATION ERROR 722 0.0130
434 HEPATOTOXICITY 287 0.0129
435 GAIT DISTURBANCE 2465 0.0129
436 ANKLE FRACTURE 198 0.0128
437 IMPAIRED WORK ABILITY 273 0.0128
438 MOUTH ULCERATION 269 0.0128
439 CELLULITIS 640 0.0127
440 ABDOMINAL ADHESIONS 40 0.0127
441 EYE INFECTION 143 0.0127
442 SPINAL OSTEOARTHRITIS 111 0.0126
443 HEPATIC ENZYME ABNORMAL 63 0.0126
444 INFLUENZA 1406 0.0126
445 GASTRIC INFECTION 48 0.0125
446 FUNGAL INFECTION 418 0.0125
447 ABDOMINAL PAIN 2909 0.0125
448 MALAISE 5442 0.0124
449 INJECTION SITE URTICARIA 304 0.0124
450 EYE OPERATION 57 0.0124
451 CHEST PAIN 2289 0.0123
452 ECTOPIC PREGNANCY 38 0.0123
453 OESOPHAGEAL CANDIDIASIS 49 0.0123
454 INJECTION SITE SWELLING 935 0.0122
455 ANAPHYLACTIC REACTION 670 0.0121
456 COVID-19 2107 0.0120
457 DECREASED APPETITE 2782 0.0120
458 SPINAL PAIN 140 0.0119
459 URINARY TRACT INFECTION 2027 0.0119
460 MASS 166 0.0119
461 COLITIS ULCERATIVE 529 0.0118
462 B-CELL LYMPHOMA 40 0.0118
463 ORAL HERPES 229 0.0117
464 INJECTION SITE BRUISING 923 0.0116
465 HEADACHE 7242 0.0115
466 OSTEOMYELITIS 209 0.0115
467 TENDERNESS 120 0.0115
468 CYSTITIS 366 0.0115
469 IRON DEFICIENCY ANAEMIA 106 0.0115
470 ARTHROPOD BITE 85 0.0115
471 HERNIA 221 0.0114
472 TOOTH EXTRACTION 142 0.0114
473 PRODUCT USE IN UNAPPROVED INDICATION 2824 0.0114
474 LYMPHOCYTE COUNT INCREASED 37 0.0113
475 RASH GENERALISED 292 0.0113
476 VIRAL INFECTION 373 0.0112
477 SKIN PLAQUE 94 0.0111
478 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 204 0.0111
479 OEDEMA PERIPHERAL 1356 0.0111
480 PYODERMA GANGRENOSUM 40 0.0111
481 STAPHYLOCOCCAL INFECTION 366 0.0111
482 LIGAMENT RUPTURE 49 0.0111
483 ORAL CANDIDIASIS 146 0.0111
484 VAGINAL INFECTION 52 0.0110
485 MUSCLE SPASMS 2012 0.0110
486 THYROID DISORDER 168 0.0109
487 INJECTION SITE HYPERSENSITIVITY 34 0.0109
488 SKIN LACERATION 118 0.0108
489 VOMITING 5063 0.0108
490 SINUS CONGESTION 144 0.0106
491 ORAL DISORDER 78 0.0106
492 HYPERTRANSAMINASAEMIA 74 0.0106
493 TENDON DISORDER 69 0.0106
494 VIRAL UPPER RESPIRATORY TRACT INFECTION 50 0.0105
495 INTERSTITIAL LUNG DISEASE 505 0.0104
496 RECTAL HAEMORRHAGE 442 0.0103
497 COLECTOMY 58 0.0103
498 IMMUNE SYSTEM DISORDER 134 0.0102
499 HEPATIC STEATOSIS 189 0.0101
500 UPPER LIMB FRACTURE 202 0.0101
501 GASTROINTESTINAL INFLAMMATION 79 0.0101
502 HYSTERECTOMY 87 0.0100
503 CLOSTRIDIUM DIFFICILE INFECTION 219 0.0100
504 WHITE BLOOD CELL COUNT INCREASED 384 0.0100
505 MULTIPLE ALLERGIES 78 0.0099
506 DERMATITIS ALLERGIC 125 0.0099
507 ABDOMINAL DISTENSION 1036 0.0099
508 BONE DENSITY ABNORMAL 37 0.0099
509 DIARRHOEA 6373 0.0099
510 CYST 122 0.0098
511 GOITRE 40 0.0098
512 ASTHENIA 3671 0.0098
513 MOVEMENT DISORDER 313 0.0097
514 OVARIAN CYST 97 0.0097
515 INJECTION SITE DISCOMFORT 102 0.0097
516 DEPRESSION 2197 0.0096
517 GINGIVITIS 52 0.0096
518 VISUAL IMPAIRMENT 1194 0.0096
519 MUSCULOSKELETAL DISCOMFORT 163 0.0095
520 BACK PAIN 2199 0.0095
521 DYSPNOEA 5328 0.0094
522 ABSCESS LIMB 40 0.0094
523 CUTANEOUS VASCULITIS 34 0.0093
524 FRACTURE 176 0.0093
525 MENINGITIS 62 0.0093
526 LYMPHADENOPATHY 327 0.0092
527 INJECTION SITE INFLAMMATION 46 0.0092
528 PROCTALGIA 59 0.0092
529 HOSPITALISATION 1409 0.0092
530 LABORATORY TEST ABNORMAL 270 0.0091
531 SPINAL COLUMN STENOSIS 43 0.0091
532 INTERVERTEBRAL DISC DEGENERATION 84 0.0091
533 INJECTION SITE HAEMATOMA 129 0.0089
534 CANDIDA INFECTION 150 0.0089
535 LYMPHOMA 137 0.0089
536 GENERALISED ERYTHEMA 50 0.0088
537 UROSEPSIS 81 0.0088
538 PANCREATITIS 463 0.0088
539 MALIGNANT MELANOMA 117 0.0087
540 IMMUNOSUPPRESSION 77 0.0087
541 OROPHARYNGEAL PAIN 808 0.0087
542 FOETAL EXPOSURE DURING PREGNANCY 709 0.0087
543 PRODUCT DOSE OMISSION IN ERROR 246 0.0087
544 BLOOD PRESSURE SYSTOLIC INCREASED 169 0.0087
545 CARPAL TUNNEL SYNDROME 121 0.0086
546 SMALL INTESTINAL OBSTRUCTION 106 0.0086
547 SKIN MASS 57 0.0085
548 BLEPHARITIS 34 0.0085
549 NO ADVERSE EVENT 1528 0.0084
550 PLEURISY 50 0.0084
551 CHOLECYSTECTOMY 96 0.0084
552 NAUSEA 6651 0.0084
553 GENERALISED OEDEMA 104 0.0084
554 WEIGHT DECREASED 2338 0.0084
555 SINUS DISORDER 165 0.0083
556 VASCULITIS 97 0.0083
557 DEMYELINATION 34 0.0083
558 SQUAMOUS CELL CARCINOMA 78 0.0083
559 CONJUNCTIVITIS 153 0.0082
560 BLOOD PRESSURE DIASTOLIC INCREASED 38 0.0082
561 FLANK PAIN 77 0.0082
562 PRODUCT PRESCRIBING ERROR 195 0.0082
563 INTERVERTEBRAL DISC PROTRUSION 178 0.0081
564 INJECTION SITE PAIN 2493 0.0081
565 STAPHYLOCOCCAL SEPSIS 40 0.0081
566 HORDEOLUM 35 0.0081
567 SKIN CANCER 174 0.0081
568 MUCOUS STOOLS 40 0.0081
569 SECRETION DISCHARGE 101 0.0081
570 QUALITY OF LIFE DECREASED 107 0.0080
571 MENISCUS INJURY 49 0.0080
572 APPENDICITIS 74 0.0079
573 GASTROENTERITIS 115 0.0079
574 SKIN DISORDER 262 0.0078
575 RESPIRATORY SYNCYTIAL VIRUS INFECTION 68 0.0078
576 FEELING HOT 478 0.0078
577 PRODUCT TEMPERATURE EXCURSION ISSUE 40 0.0078
578 UNDERDOSE 567 0.0078
579 EYE INFLAMMATION 74 0.0077
580 SINUS HEADACHE 46 0.0077
581 INCREASED TENDENCY TO BRUISE 71 0.0077
582 BOWEL MOVEMENT IRREGULARITY 59 0.0077
583 DIARRHOEA HAEMORRHAGIC 72 0.0077
584 ONYCHOCLASIS 53 0.0077
585 NERVE COMPRESSION 71 0.0077
586 DIZZINESS 3835 0.0077
587 THERAPEUTIC PRODUCT EFFECT DELAYED 35 0.0077
588 ABDOMINAL HERNIA 35 0.0077
589 NONSPECIFIC REACTION 42 0.0076
590 PRODUCT QUALITY ISSUE 1038 0.0076
591 DRUG EFFECT DECREASED 411 0.0076
592 THERAPY CESSATION 391 0.0076
593 DRUG EFFECT INCOMPLETE 276 0.0076
594 ALANINE AMINOTRANSFERASE INCREASED 465 0.0076
595 RHINITIS 61 0.0076
596 BACTERIAL INFECTION 141 0.0076
597 INFLUENZA LIKE ILLNESS 621 0.0075
598 INJECTION SITE ERYTHEMA 933 0.0075
599 ASPARTATE AMINOTRANSFERASE INCREASED 397 0.0075
600 ORGANISING PNEUMONIA 37 0.0075
601 STILLBIRTH 36 0.0074
602 RASH PUSTULAR 54 0.0074
603 SPINAL DISORDER 70 0.0074
604 ATELECTASIS 71 0.0073
605 PHOTOSENSITIVITY REACTION 121 0.0073
606 TOOTH DISORDER 162 0.0073
607 PNEUMOCYSTIS JIROVECII PNEUMONIA 73 0.0073
608 NASAL CONGESTION 426 0.0072
609 HYPOCALCAEMIA 137 0.0072
610 CATARACT 430 0.0072
611 PRODUCT STORAGE ERROR 632 0.0072
612 DERMATITIS 151 0.0072
613 INTESTINAL OBSTRUCTION 270 0.0072
614 TOOTH FRACTURE 78 0.0071
615 FOOD ALLERGY 54 0.0070
616 PRURITUS GENERALISED 150 0.0069
617 ENTERITIS 44 0.0069
618 PNEUMONIA BACTERIAL 63 0.0069
619 BLOOD IRON DECREASED 81 0.0068
620 ACCIDENT 81 0.0068
621 LUNG INFECTION 105 0.0068
622 INJECTION SITE IRRITATION 86 0.0068
623 BURNING SENSATION 473 0.0067
624 LIQUID PRODUCT PHYSICAL ISSUE 49 0.0067
625 INJECTION SITE DISCHARGE 36 0.0067
626 LIGAMENT SPRAIN 66 0.0067
627 FLUID RETENTION 338 0.0066
628 ABORTION INDUCED 62 0.0066
629 SKIN SWELLING 57 0.0066
630 GASTROINTESTINAL PAIN 72 0.0065
631 FOOD POISONING 35 0.0065
632 HUNGER 91 0.0065
633 INJECTION SITE PRURITUS 437 0.0065
634 HAEMATOCHEZIA 359 0.0065
635 NEOPLASM MALIGNANT 433 0.0065
636 ERYTHEMA 1332 0.0065
637 MOTOR DYSFUNCTION 66 0.0065
638 ROTATOR CUFF SYNDROME 83 0.0065
639 SQUAMOUS CELL CARCINOMA OF SKIN 39 0.0065
640 CONCUSSION 50 0.0065
641 PHARYNGEAL SWELLING 63 0.0064
642 MUSCULOSKELETAL CHEST PAIN 99 0.0064
643 OPTIC NEURITIS 58 0.0064
644 SKIN WARM 37 0.0064
645 SEASONAL ALLERGY 90 0.0064
646 HIATUS HERNIA 82 0.0063
647 DIVERTICULUM 45 0.0063
648 SCAR 108 0.0063
649 ANXIETY 1795 0.0063
650 COLITIS 238 0.0063
651 EYE DISORDER 206 0.0063
652 BREAST MASS 42 0.0062
653 INTENTIONAL PRODUCT MISUSE 546 0.0062
654 INTESTINAL PERFORATION 70 0.0062
655 DECREASED IMMUNE RESPONSIVENESS 61 0.0062
656 HYPERAESTHESIA 51 0.0062
657 TENDON PAIN 47 0.0062
658 VITAMIN D DECREASED 53 0.0062
659 APHTHOUS ULCER 48 0.0062
660 UTERINE LEIOMYOMA 45 0.0062
661 LOSS OF CONSCIOUSNESS 773 0.0060
662 UNEVALUABLE EVENT 452 0.0060
663 STENT PLACEMENT 48 0.0059
664 RASH ERYTHEMATOUS 284 0.0059
665 BREAST CANCER STAGE I 55 0.0059
666 ENCEPHALITIS 41 0.0059
667 SCAB 67 0.0059
668 SYMPTOM RECURRENCE 35 0.0058
669 WRIST FRACTURE 70 0.0058
670 DIABETES MELLITUS 442 0.0058
671 AUTOIMMUNE HEPATITIS 40 0.0057
672 FACIAL PARALYSIS 49 0.0057
673 ANAPHYLACTIC SHOCK 148 0.0057
674 APHONIA 80 0.0057
675 ESCHERICHIA INFECTION 47 0.0057
676 GROIN PAIN 50 0.0057
677 BLOOD TEST ABNORMAL 79 0.0056
678 PLATELET COUNT INCREASED 73 0.0056
679 INJECTION SITE WARMTH 115 0.0056
680 SWELLING FACE 360 0.0055
681 BLOOD PRESSURE FLUCTUATION 132 0.0055
682 BRAIN FOG 86 0.0055
683 PRODUCT SUPPLY ISSUE 39 0.0055
684 POST PROCEDURAL COMPLICATION 104 0.0054
685 COUGH 1515 0.0054
686 SKIN DISCOLOURATION 248 0.0054
687 NEURALGIA 130 0.0053
688 INJECTION SITE HAEMORRHAGE 427 0.0053
689 FALL 1771 0.0053
690 DEAFNESS 139 0.0053
691 FEEDING DISORDER 107 0.0053
692 TENDON RUPTURE 65 0.0053
693 LIMB INJURY 143 0.0053
694 SPINAL FRACTURE 104 0.0052
695 SKIN LESION 142 0.0052
696 DERMATITIS CONTACT 59 0.0052
697 INJECTION SITE MASS 191 0.0052
698 EAR DISCOMFORT 53 0.0052
699 CORONAVIRUS INFECTION 34 0.0051
700 PELVIC FRACTURE 40 0.0051
701 SCRATCH 54 0.0051
702 TREATMENT NONCOMPLIANCE 279 0.0051
703 FRUSTRATION TOLERANCE DECREASED 41 0.0051
704 MENSTRUAL DISORDER 42 0.0051
705 GASTRITIS 133 0.0050
706 PLEURAL EFFUSION 307 0.0050
707 BLOOD ALBUMIN DECREASED 40 0.0050
708 INCORRECT PRODUCT ADMINISTRATION DURATION 109 0.0050
709 TACHYCARDIA 447 0.0050
710 VITAMIN D DEFICIENCY 49 0.0050
711 CARDIAC OPERATION 43 0.0050
712 OCULAR HYPERAEMIA 237 0.0050
713 GALLBLADDER DISORDER 89 0.0050
714 PRODUCTIVE COUGH 238 0.0050
715 RHINORRHOEA 320 0.0049
716 HAND FRACTURE 35 0.0049
717 BLOOD PRESSURE INCREASED 747 0.0049
718 BODY TEMPERATURE DECREASED 48 0.0049
719 PHOTOPHOBIA 91 0.0048
720 DRY EYE 240 0.0048
721 SEPTIC SHOCK 207 0.0048
722 UPPER-AIRWAY COUGH SYNDROME 39 0.0047
723 DYSSTASIA 136 0.0047
724 RENAL DISORDER 217 0.0047
725 ATRIAL FIBRILLATION 452 0.0046
726 MUSCLE STRAIN 40 0.0046
727 SEPSIS 512 0.0046
728 PULMONARY THROMBOSIS 50 0.0046
729 COVID-19 PNEUMONIA 54 0.0046
730 INJECTION SITE NODULE 50 0.0045
731 ECZEMA 236 0.0045
732 PHARYNGEAL OEDEMA 69 0.0045
733 HYPOKALAEMIA 207 0.0045
734 GINGIVAL BLEEDING 61 0.0045
735 POOR QUALITY SLEEP 95 0.0044
736 HAEMORRHOIDS 86 0.0044
737 THERAPY CHANGE 43 0.0044
738 LEUKOPENIA 216 0.0043
739 COLON CANCER 64 0.0043
740 POLLAKIURIA 178 0.0043
741 HYPERSOMNIA 122 0.0043
742 HYPERTENSIVE CRISIS 47 0.0042
743 FEELING JITTERY 80 0.0042
744 CHILLS 491 0.0042
745 CARDIOVASCULAR DISORDER 106 0.0042
746 OSTEOPENIA 63 0.0041
747 CLOSTRIDIUM DIFFICILE COLITIS 44 0.0041
748 PRODUCT DISPENSING ERROR 90 0.0041
749 RIB FRACTURE 85 0.0041
750 INCORRECT DOSE ADMINISTERED 938 0.0041
751 EYE SWELLING 152 0.0041
752 THYROID CANCER 49 0.0041
753 DENTAL CARIES 45 0.0041
754 LUNG NEOPLASM MALIGNANT 165 0.0040
755 GASTRIC ULCER 76 0.0040
756 FEELING ABNORMAL 948 0.0040
757 BLOOD URINE PRESENT 75 0.0039
758 AFFECT LABILITY 38 0.0039
759 VENTRICULAR EXTRASYSTOLES 41 0.0039
760 MALNUTRITION 44 0.0039
761 ORAL PAIN 88 0.0039
762 ASPIRATION 43 0.0039
763 CHOLELITHIASIS 128 0.0039
764 PALPITATIONS 457 0.0039
765 LIP SWELLING 129 0.0039
766 RENAL PAIN 41 0.0039
767 TOOTHACHE 70 0.0039
768 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 201 0.0038
769 BONE DISORDER 70 0.0038
770 SNEEZING 86 0.0038
771 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 210 0.0038
772 BLOOD POTASSIUM DECREASED 115 0.0038
773 BREAST CANCER 355 0.0038
774 OVARIAN CANCER 35 0.0038
775 SPUTUM DISCOLOURED 36 0.0038
776 VERTIGO 231 0.0038
777 THROAT TIGHTNESS 102 0.0038
778 HIP FRACTURE 121 0.0038
779 THROMBOSIS 302 0.0038
780 FEMUR FRACTURE 115 0.0037
781 CHOLECYSTITIS 44 0.0037
782 BREAST PAIN 39 0.0037
783 NEOPLASM 42 0.0037
784 ABDOMINAL PAIN LOWER 92 0.0036
785 DEVICE RELATED INFECTION 56 0.0036
786 SLUGGISHNESS 37 0.0036
787 HYPOAESTHESIA ORAL 54 0.0036
788 PROCEDURAL PAIN 97 0.0035
789 MULTIPLE FRACTURES 57 0.0035
790 DRUG RESISTANCE 89 0.0035
791 DECREASED ACTIVITY 37 0.0034
792 BLOOD PRESSURE ABNORMAL 68 0.0034
793 DYSPHONIA 198 0.0034
794 SWOLLEN TONGUE 105 0.0034
795 GOUT 60 0.0033
796 TRANSAMINASES INCREASED 74 0.0033
797 INJECTION SITE INDURATION 43 0.0033
798 OCULAR DISCOMFORT 37 0.0033
799 MYALGIA 553 0.0032
800 RASH MACULAR 113 0.0032
801 SKIN BURNING SENSATION 231 0.0032
802 CHEST DISCOMFORT 328 0.0032
803 IMPAIRED QUALITY OF LIFE 46 0.0032
804 MOOD SWINGS 100 0.0031
805 NEUROPATHY PERIPHERAL 296 0.0031
806 RASH MACULO-PAPULAR 69 0.0031
807 RED BLOOD CELL COUNT DECREASED 88 0.0031
808 EATING DISORDER 65 0.0030
809 PARAESTHESIA ORAL 44 0.0030
810 LOCAL SWELLING 53 0.0030
811 DYSURIA 111 0.0030
812 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 213 0.0030
813 EYE PAIN 167 0.0030
814 LIVER FUNCTION TEST ABNORMAL 86 0.0030
815 RASH PAPULAR 66 0.0029
816 HYPOTHYROIDISM 94 0.0029
817 HEAD DISCOMFORT 52 0.0029
818 SLEEP APNOEA SYNDROME 56 0.0029
819 PAIN IN JAW 83 0.0029
820 SYNCOPE 293 0.0029
821 MIDDLE INSOMNIA 54 0.0029
822 LACRIMATION INCREASED 87 0.0029
823 HYPERHIDROSIS 367 0.0028
824 GAMMA-GLUTAMYLTRANSFERASE INCREASED 63 0.0028
825 MUSCLE ATROPHY 36 0.0028
826 DISEASE RECURRENCE 135 0.0028
827 ACNE 215 0.0028
828 PNEUMONITIS 77 0.0028
829 HYPOKINESIA 41 0.0028
830 FLATULENCE 160 0.0028
831 DRY SKIN 376 0.0028
832 HEART RATE INCREASED 278 0.0028
833 DEHYDRATION 372 0.0028
834 NO THERAPEUTIC RESPONSE 34 0.0028
835 IMPAIRED GASTRIC EMPTYING 38 0.0028
836 CARDIAC DISORDER 260 0.0028
837 HAEMATOMA 72 0.0028
838 HAEMORRHAGE 290 0.0028
839 HAEMATOCRIT DECREASED 55 0.0028
840 FAECES DISCOLOURED 60 0.0028
841 INJECTION SITE EXTRAVASATION 34 0.0028
842 THROAT IRRITATION 122 0.0027
843 MUSCLE TIGHTNESS 44 0.0027
844 SKIN EXFOLIATION 221 0.0026
845 HOT FLUSH 195 0.0026
846 THERAPEUTIC RESPONSE UNEXPECTED 116 0.0026
847 RETCHING 55 0.0026
848 COLD SWEAT 45 0.0026
849 DEEP VEIN THROMBOSIS 165 0.0025
850 WHITE BLOOD CELL COUNT DECREASED 275 0.0025
851 BONE PAIN 147 0.0025
852 NERVOUS SYSTEM DISORDER 78 0.0025
853 VISION BLURRED 341 0.0025
854 CORONARY ARTERY OCCLUSION 34 0.0025
855 SOMNOLENCE 489 0.0024
856 PAIN OF SKIN 65 0.0024
857 TINNITUS 110 0.0024
858 BLOOD CREATININE INCREASED 156 0.0024
859 EYE PRURITUS 80 0.0024
860 PARALYSIS 34 0.0024
861 AGEUSIA 59 0.0024
862 HAEMOGLOBIN DECREASED 242 0.0024
863 DEPRESSED MOOD 124 0.0023
864 HEAD INJURY 74 0.0023
865 FEELING COLD 65 0.0023
866 MYOCARDIAL INFARCTION 405 0.0023
867 PERICARDIAL EFFUSION 53 0.0023
868 ACUTE RESPIRATORY DISTRESS SYNDROME 40 0.0023
869 FACE OEDEMA 38 0.0023
870 INCREASED APPETITE 43 0.0022
871 EPISTAXIS 168 0.0022
872 PNEUMOTHORAX 35 0.0022
873 ANAEMIA 419 0.0022
874 BONE DENSITY DECREASED 68 0.0022
875 HEART RATE IRREGULAR 49 0.0022
876 NERVOUSNESS 112 0.0021
877 TRANSIENT ISCHAEMIC ATTACK 72 0.0021
878 OSTEONECROSIS 70 0.0021
879 DRUG DOSE OMISSION 352 0.0021
880 THIRST 38 0.0021
881 MUSCLE TWITCHING 49 0.0021
882 EMOTIONAL DISORDER 64 0.0021
883 ACTIVITIES OF DAILY LIVING IMPAIRED 41 0.0021
884 MENTAL DISORDER 90 0.0021
885 SKIN FISSURES 40 0.0020
886 DIPLOPIA 53 0.0020
887 PELVIC PAIN 37 0.0020
888 HYPOTENSION 405 0.0020
889 BLOOD SODIUM DECREASED 38 0.0020
890 CORONARY ARTERY DISEASE 61 0.0020
891 BLOOD ALKALINE PHOSPHATASE INCREASED 50 0.0020
892 PULMONARY EMBOLISM 191 0.0020
893 THROMBOCYTOPENIA 223 0.0020
894 BALANCE DISORDER 172 0.0020
895 ANGINA PECTORIS 57 0.0020
896 BLOOD PRESSURE DECREASED 132 0.0020
897 MUCOSAL INFLAMMATION 52 0.0020
898 VAGINAL HAEMORRHAGE 86 0.0020
899 ARRHYTHMIA 93 0.0020
900 CONSTIPATION 428 0.0020
901 MOOD ALTERED 53 0.0019
902 SKIN IRRITATION 89 0.0019
903 HEART RATE DECREASED 68 0.0019
904 DEMENTIA 54 0.0019
905 LETHARGY 111 0.0019
906 PROSTATE CANCER 153 0.0019
907 EYE IRRITATION 109 0.0019
908 CARDIAC FAILURE 152 0.0019
909 PRESYNCOPE 46 0.0019
910 OVERDOSE 407 0.0019
911 PALLOR 51 0.0019
912 DYSPNOEA EXERTIONAL 69 0.0018
913 PANCREATITIS ACUTE 41 0.0018
914 CHROMATURIA 41 0.0018
915 HAEMATEMESIS 46 0.0018
916 ANGIOEDEMA 80 0.0018
917 PERITONITIS 37 0.0018
918 PLATELET COUNT DECREASED 188 0.0018
919 DEVICE ISSUE 158 0.0018
920 DEVICE DIFFICULT TO USE 116 0.0018
921 RESPIRATORY DISTRESS 48 0.0017
922 DEATH 1483 0.0017
923 DRUG EXPOSURE DURING PREGNANCY 58 0.0017
924 MENTAL STATUS CHANGES 47 0.0017
925 DYSPHAGIA 160 0.0017
926 SPEECH DISORDER 88 0.0017
927 PULMONARY OEDEMA 75 0.0017
928 PANIC ATTACK 60 0.0016
929 CARDIAC FAILURE CONGESTIVE 132 0.0016
930 URINARY INCONTINENCE 48 0.0016
931 CEREBROVASCULAR ACCIDENT 271 0.0016
932 MENSTRUATION IRREGULAR 41 0.0015
933 TREMOR 254 0.0015
934 ACUTE MYOCARDIAL INFARCTION 45 0.0015
935 RENAL IMPAIRMENT 127 0.0015
936 SEIZURE 172 0.0015
937 DIABETIC KETOACIDOSIS 35 0.0015
938 ABASIA 36 0.0015
939 BLINDNESS 59 0.0014
940 HYPOACUSIS 62 0.0014
941 BLOOD GLUCOSE INCREASED 271 0.0014
942 CEREBRAL INFARCTION 35 0.0014
943 CRYING 52 0.0014
944 RESPIRATORY FAILURE 104 0.0014
945 JAUNDICE 38 0.0014
946 FLUSHING 140 0.0014
947 SUICIDAL IDEATION 123 0.0013
948 HAEMATURIA 46 0.0013
949 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 269 0.0013
950 MULTIPLE SCLEROSIS 63 0.0013
951 COGNITIVE DISORDER 61 0.0013
952 IRRITABILITY 77 0.0013
953 MYELOSUPPRESSION 46 0.0013
954 MULTIPLE ORGAN DYSFUNCTION SYNDROME 36 0.0013
955 DERMATITIS ATOPIC 67 0.0013
956 OXYGEN SATURATION DECREASED 71 0.0013
957 BLOOD GLUCOSE DECREASED 60 0.0012
958 HEPATIC FUNCTION ABNORMAL 46 0.0012
959 DYSGEUSIA 90 0.0012
960 APHASIA 36 0.0012
961 NEUTROPENIA 154 0.0011
962 HEPATIC FAILURE 34 0.0011
963 RENAL FAILURE 146 0.0011
964 CEREBRAL HAEMORRHAGE 39 0.0011
965 DISTURBANCE IN ATTENTION 58 0.0011
966 ACCIDENTAL OVERDOSE 39 0.0011
967 GASTROINTESTINAL HAEMORRHAGE 87 0.0010
968 DYSARTHRIA 39 0.0010
969 CARDIO-RESPIRATORY ARREST 43 0.0010
970 DEVICE MALFUNCTION 72 0.0010
971 EXPIRED PRODUCT ADMINISTERED 34 0.0010
972 CONVULSION 58 0.0010
973 RENAL FAILURE ACUTE 43 0.0010
974 DISEASE PROGRESSION 119 0.0010
975 RESTLESSNESS 35 0.0010
976 EXTRA DOSE ADMINISTERED 37 0.0009
977 DISORIENTATION 35 0.0009
978 BLADDER CANCER 47 0.0008
979 COMA 38 0.0008
980 CARDIAC ARREST 65 0.0008
981 HYPONATRAEMIA 36 0.0006
982 AGITATION 46 0.0006
983 PANCYTOPENIA 35 0.0006
984 SUICIDE ATTEMPT 37 0.0006
985 DRUG INTERACTION 92 0.0006
986 ACUTE KIDNEY INJURY 87 0.0006
987 CHRONIC KIDNEY DISEASE 39 0.0005
988 HALLUCINATION 35 0.0005
989 TOXICITY TO VARIOUS AGENTS 74 0.0004
990 EMOTIONAL DISTRESS 45 0.0004
991 ACCIDENTAL EXPOSURE TO PRODUCT 35 0.0003
992 DRUG DEPENDENCE 34 0.0002